Japan’s Chugai applies for approval of antibody treatment for COVID-19

Chugai Pharmaceutical Co said on Tuesday it applied for regulatory approval in Japan of an antibody treatment for COVID-19. The filing is for the antibody cocktail casirivimab and imdevimab and is …
( read original story …)